Kinetic binding assay using biolayer interferometry.

NK Neville K. Kisalu
LP Lais D. Pereira
KE Keenan Ernste
YF Yevel Flores-Garcia
AI Azza H. Idris
MA Mangaiarkarasi Asokan
MD Marlon Dillon
SM Scott MacDonald
WS Wei Shi
XC Xuejun Chen
AP Amarendra Pegu
AS Arne Schön
FZ Fidel Zavala
AB Alejandro B. Balazs
JF Joseph R. Francica
RS Robert A. Seder
ask Ask a question
Favorite

mAbs were purified on a Superdex200 Hi Load 16/600 column to remove aggregates. BLI analysis was performed on a Octet RED384 system using receptors (Acro Biosystems, FCM-H5286, FCM-C5284, and FCM-M82W5) or rPfCSP and PfCSP peptides loaded on HIS1K or SAX biosensors (ForteBio, 18-5122 and 18-5117) and probed into mAbs in a 2-fold dilution series. Assay conditions were individually optimized for each receptor-ligand pair. Data were fit using a 1:1 model on Octet Data Analysis Software version 12.0.2.3 (Molecular Devices LLC). Serial antibody concentrations used were 20, 10, 5, 2.5, and 1.25 μg/mL for pH 6.0 and 2000, 100, 50, 25, and 12.5 μg/mL for pH 7.4 for binding to the receptors, whereas antibody concentrations used for binding to rPfCSP were 2, 1, 0.5, 0.25, and 0.125 μg/mL.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A